TEMPORAL TRENDS IN THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN THE UK WITH REFERENCE TO BEST PRACTICE

TEMPORAL TRENDS IN THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN THE UK WITH REFERENCE TO BEST PRACTICE

Bibliografski detalji
Glavni autori:	Edwards, C, Arden, N, Campbell, J, van Staa, T, Housden, C, Sargeant, I
Format:	Conference item
Izdano:	2012

Slični predmeti

REGIONAL DIFFERENCES IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
od: Edwards, C, i dr.
Izdano: (2012)

Regional and temporal variation in the treatment of rheumatoid arthritis across the UK: a descriptive register-based cohort study
od: Edwards, C, i dr.
Izdano: (2012)

Myocardial infarction in rheumatoid arthritis: The effects of DMARDs and prednisolone
od: Edwards, C, i dr.
Izdano: (2008)

Individual DMARDs have different effects on the likelihood of developing septic arthritis in adults with rheumatoid arthritis
od: Edwards, C, i dr.
Izdano: (2005)

Temporal Trends In The Prescribing Of Disease Modifying Anti-Rheumatic Drugs For Rheumatoid Arthritis and The Impact Of Guidelines.
od: Wallace, G, i dr.
Izdano: (2013)

Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry data
od: Hawley, S, i dr.
Izdano: (2019)

The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis.
od: Edwards, C, i dr.
Izdano: (2007)

Variation in the use of biologics in the management of rheumatoid arthritis across the UK.
od: Choy, E, i dr.
Izdano: (2012)

Myocardial infarction in rheumatoid arthritis: The effects of traditional risk factors, anti-hypertensive and lipid-lowering medication
od: Edwards, C, i dr.
Izdano: (2008)

The increased risk of myocardial infarction in patients with rheumatoid arthritis is greatest in young women and is not due to traditional risk factors
od: Arden, N, i dr.
Izdano: (2006)

T cell genetics and rheumatoid arthritis (RA)
od: Wordsworth, P
Izdano: (1998)

JAK ACADEMY in Rheumatoid Arthritis (RA)
od: Roberto Caporali, i dr.
Izdano: (2018-09-01)

Descriptive epidemiology of hip and knee replacement in rheumatoid arthritis: an analysis of UK electronic medical records
od: Hawley, S, i dr.
Izdano: (2019)

Biologics in rheumatoid arthritis (RA) – recommendations for Swiss practice
od: BA Michel
Izdano: (2011-05-01)

Bone turnover in early rheumatoid arthritis (RA)
od: Sambrook, P, i dr.
Izdano: (1985)

The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database.
od: Edwards, C, i dr.
Izdano: (2005)

Rheumatoid arthritis: RA-lowering cardiovascular risk with statins
od: Lee, J, i dr.
Izdano: (2010)

Rheumatoid arthritis: RA--lowering cardiovascular risk with statins.
od: Lee, J, i dr.
Izdano: (2010)

Adenosine Deaminase (ADA) in Rheumatoid Arthritis in patients (RA)
od: Huda Th. Al-Marsomi
Izdano: (2009-07-01)

IL-1Ra: its role in rheumatoid arthritis
od: M. Cutolo
Izdano: (2011-09-01)

Immune, metabolism and therapeutic targets in RA (Rheumatoid Arthritis)
od: Liu Keying
Izdano: (2022-01-01)

The effect of TNF blockade on insulin resistance in patients with rheumatoid arthritis
od: Edwards, C, i dr.
Izdano: (2006)

The changing use of disease-modifying anti-rheumatic drugs in individuals with RA from the general practice research database (GPRD).
od: Edwards, C, i dr.
Izdano: (2004)

The changing use of disease-modifying anti-rheumatic drugs in individuals with RA from The General Practice Research Database (GPRD) the changing use of disease-modifying anti-rheumatic drugs for RA from The General Practice Research Database
od: Edwards, C, i dr.
Izdano: (2005)

Evolving the management of rheumatoid arthritis (eRA) through development of practical and educational tools
od: Van De Laar, M, i dr.
Izdano: (2019)

PLANTAR FOOT PRESSURES ARE NOT RELATED TO DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS
od: Gay, A, i dr.
Izdano: (2009)

Using ultrasound to image the foot in rheumatoid arthritis: Current understanding, challenges and future scope
od: Bowen, C, i dr.
Izdano: (2013)

Interleukin 10 (IL-10) haplotypes are associated with rheumatoid arthritis (RA).
od: MacKay, K, i dr.
Izdano: (2000)

A survey of a footwear service for people with Rheumatoid Arthritis (RA)
od: Field Robert
Izdano: (2010-12-01)

Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA
od: Vibeke Strand, i dr.
Izdano: (2024-08-01)

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients
od: Isaacs, JD, i dr.
Izdano: (2022)

Outcome assessment in rheumatoid arthritis: The patient says the best
od: Durga Prasanna Misra, i dr.
Izdano: (2017-01-01)

Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients
od: Judge, AD, i dr.
Izdano: (2017)

Comparative Distribution of Ultrasound-Detectable Forefoot Bursae in Patients With Osteoarthritis and Rheumatoid Arthritis
od: Hooper, L, i dr.
Izdano: (2014)

The clinical importance of ultrasound detectable forefoot bursae in rheumatoid arthritis.
od: Bowen, C, i dr.
Izdano: (2010)

The role of IL-10 in rheumatoid arthritis (RA) in two ethnically diverse populations.
od: MacKay, K, i dr.
Izdano: (1999)

PARTICULAR GENETIC-VARIANTS OF TYPE-II COLLAGEN ARE NOT ASSOCIATED WITH RHEUMATOID-ARTHRITIS (RA)
od: Pile, K, i dr.
Izdano: (1992)

Influenza Vaccination of Patients With Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA)
od: Ljudmila Stojanovich
Izdano: (2006-01-01)

Immunodiagnostic Significance of Anti-RA33 Autoantibodies in Saudi Patients with Rheumatoid Arthritis
od: Jamil A. Al-Mughales
Izdano: (2015-01-01)

The importance of diet, intestinal microbiome and physical activity in Rheumatoid Arthritis (RA) - Review
od: Joanna Antczak, i dr.
Izdano: (2024-07-01)